Characterization of the heparan sulfate and chondroitin sulfate assembly sites in CD44

被引:58
作者
Greenfield, B
Wang, WC
Marquardt, H
Piepkorn, M
Wolff, EA
Aruffo, A
Bennett, KL
机构
[1] Bristol Myers Squibb Pharmaceut Res Inst, Princeton, NJ 08543 USA
[2] Univ Washington, Dept Dermatol, Seattle, WA 98105 USA
关键词
D O I
10.1074/jbc.274.4.2511
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Isoforms of CD44 are differentially modified by the glycosaminoglycans (GAGs) chondroitin sulfate (CS), heparan sulfate (HS), and keratan sulfate. GAG assembly occurs at serines followed by glycines (SG), but not all SG are utilized. Seven SG motifs are distributed in five CD44 exons, and in this paper we identify the HS and CS assembly sites that are utilized in CD44. Not. all the CD44 SG sites are modified. The SGSG motif in CD44 exon V3 is the only HS assembly site; this site is also modified with CS, HS and CS attachment at that site was eliminated by mutation of the serines in the V3 motif to alanine (AGAG), Exon E5 is the only other CD44 exon that supports GAG assembly and is modified with CS. Using a number of recombinant CD44 protein fragments we show herein that the eight amino acids located downstream of the SGSG site in V3 are responsible for the specific addition of HS to this site. If the eight amino acids located downstream from the first SIG site in CD44 exon E5 are exchanged with those located downstream of the SGSG site in exon V3, the SG site in E5 becomes modified with HS and CS, Likewise if the eight amino acids found downstream from the first SG in E5 are placed downstream from the SGSG in V3, this site is modified with CS but not HS. We also show that these sequences cannot direct the modification of CD44 with; HS from a distance. Constructs containing CD44 exon V3 in which the SGSG motif was mutated to AGAG were not modified with HS even though they contained other SG motifs. Thus, a number of sequence and structural requirements that dictate GAG synthesis on CD44 have been identified.
引用
收藏
页码:2511 / 2517
页数:7
相关论文
共 23 条
[1]   CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE [J].
ARUFFO, A ;
STAMENKOVIC, I ;
MELNICK, M ;
UNDERHILL, CB ;
SEED, B .
CELL, 1990, 61 (07) :1303-1313
[2]   REGULATION OF CD44 BINDING TO HYALURONAN BY GLYCOSYLATION OF VARIABLY SPLICED EXONS [J].
BENNETT, KL ;
MODRELL, B ;
GREENFIELD, B ;
BARTOLAZZI, A ;
STAMENKOVIC, I ;
PEACH, R ;
JACKSON, DG ;
SPRING, F ;
ARUFFO, A .
JOURNAL OF CELL BIOLOGY, 1995, 131 (06) :1623-1633
[3]   CD44 ISOFORMS CONTAINING EXON V3 ARE RESPONSIBLE FOR THE PRESENTATION OF HEPARIN-BINDING GROWTH-FACTOR [J].
BENNETT, KL ;
JACKSON, DG ;
SIMON, JC ;
TANCZOS, E ;
PEACH, R ;
MODRELL, B ;
STAMENKOVIC, I ;
PLOWMAN, G ;
ARUFFO, A .
JOURNAL OF CELL BIOLOGY, 1995, 128 (04) :687-698
[4]   HUMAN KERATINOCYTES EXPRESS A NEW CD44 CORE PROTEIN (CD44E) AS A HEPARAN-SULFATE INTRINSIC MEMBRANE PROTEOGLYCAN WITH ADDITIONAL EXONS [J].
BROWN, TA ;
BOUCHARD, T ;
STJOHN, T ;
WAYNER, E ;
CARTER, WG .
JOURNAL OF CELL BIOLOGY, 1991, 113 (01) :207-221
[5]   EFFECTS OF CYCLOHEXIMIDE, BREFELDIN-A, SURAMIN, HEPARIN AND PRIMAQUINE ON PROTEOGLYCAN AND GLYCOSAMINOGLYCAN BIOSYNTHESIS IN HUMAN EMBRYONIC SKIN FIBROBLASTS [J].
FRANSSON, LA ;
KARLSSON, P ;
SCHMIDTCHEN, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1137 (03) :287-297
[6]  
FRITZ TA, 1994, J BIOL CHEM, V269, P300
[7]   A NEW VARIANT OF GLYCOPROTEIN CD44 CONFERS METASTATIC POTENTIAL TO RAT CARCINOMA-CELLS [J].
GUNTHERT, U ;
HOFMANN, M ;
RUDY, W ;
REBER, S ;
ZOLLER, M ;
HAUSSMANN, I ;
MATZKU, S ;
WENZEL, A ;
PONTA, H ;
HERRLICH, P .
CELL, 1991, 65 (01) :13-24
[8]  
HARDY MR, 1989, METHOD ENZYMOL, V179, P76
[9]   CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix [J].
Henke, CA ;
Roongta, U ;
Mickelson, DJ ;
Knutson, JR ;
McCarthy, JB .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) :2541-2552
[10]   SITE-DIRECTED MUTAGENESIS BY OVERLAP EXTENSION USING THE POLYMERASE CHAIN-REACTION [J].
HO, SN ;
HUNT, HD ;
HORTON, RM ;
PULLEN, JK ;
PEASE, LR .
GENE, 1989, 77 (01) :51-59